文献速递新发突发、热带与寄生虫病

曼氏血吸虫感染与粪钙卫蛋白肠道炎症标志物相关

Schistosoma mansoni Infections Are Associated With Fecal Calprotectin Markers of Gut Inflammation After Accounting for HIV, Hepatitis B, and Malaria.
PubMed 文献 · J Infect Dis · 2026-01-01

在乌干达Pakwach区SchistoTrack队列中嵌套的横断面研究纳入640名6-85岁参与者,以Kato-Katz法检测曼氏血吸虫,用ELISA测定粪钙卫蛋白(fCal),并在校正疟疾、HIV、HBV及社会人口学协变量后分析其关联。结果显示曼氏血吸虫感染强度与各项fCal结局正相关,HIV与fCal≥100 µg/g相关。

要点

  • 曼氏血吸虫感染强度与fCal可检出、≥100 µg/g、>250 µg/g及连续值均正相关
  • 校正HIV、疟疾、HBV后血吸虫感染与肠道炎症标志物的关联仍存在
  • 建议将fCal阈值纳入临床指南以改善血吸虫病相关疾病管理

核心结论

  • 在反复接受吡喹酮治疗的慢性感染人群中,曼氏血吸虫感染与持续且具临床意义的肠道炎症水平相关。
  • 将fCal阈值整合进临床指南可能改善血吸虫病相关疾病负担的管理。

研究设计与样本

  • 在乌干达Pakwach区SchistoTrack队列中开展的横断面研究。
  • 2024年纳入640名6-85岁参与者,以Kato-Katz法检测曼氏血吸虫,以ELISA测定粪钙卫蛋白。
  • fCal按二分类结局(可检出、≥100 µg/g、>250 µg/g)及自然对数转换连续值分析。
  • 采用逻辑回归并结合协变量选择,考察疟疾、HIV、HBV及社会人口学协变量。

主要发现

  • 74.4%的参与者fCal可检出,22.3% fCal≥100 µg/g,7% fCal>250 µg/g。
  • 曼氏血吸虫感染率为49.1%。
  • 感染状态与除连续fCal结局外的其余fCal结局正相关。
  • HIV与fCal≥100 µg/g相关(OR 2.52),疟疾与HBV未提供有效信息。

临床怎么用

  • 对慢性血吸虫感染人群可考虑检测fCal以评估肠道炎症相关疾病负担。
  • 解读fCal升高时需同时考虑HIV感染等共存的肠道炎症影响因素。

局限性

  • 横断面设计无法确立血吸虫感染与肠道炎症之间的因果时序。
  • 研究对象为乌干达单一地区反复治疗的慢性感染人群,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of gut inflammation for intestinal schistosomiasis remains poorly understood in chronically infected and repeatedly treated populations. METHODS: We conducted a cross-sectional study nested in the SchistoTrack cohort within Pakwach district, Uganda. In 2024, 640 participants aged 6-85 years were examined for Schistosoma mansoni by Kato-Katz. Fecal calprotectin (fCal) concentration was measured by enzyme-linked immunosorbent assays. Fecal calprotectin was analyzed as binary outcomes (detectable, ≥100 µg/g, >250 µg/g) and natural log-transformed continuous values. Co-endemic infections (malaria, HIV, hepatitis B [HBV]) and sociodemographic covariates were investigated in logistic regressions with covariate selection. RESULTS: 74.4% of participants had detectable fCal, 22.3% had fCal ≥100 µg/g, and 7% had fCal >250 µg/g. Schistosoma mansoni prevalence was 49.1%. Infection intensity was positively associated with all fCal outcomes (detectable: OR 1.20, ≥100 µg/g: OR 1.11, >250 µg/g: OR 1.26; continuous: β .06) while infection status was positively related to all but the continuous fCal outcome. HIV was associated with fCal ≥100 µg/g (OR 2.52), while malaria and HBV were uninformative. CONCLUSIONS: Schistosoma mansoni infections are characterized by persistent, clinically concerning levels of gut inflammation in chronically infected populations with repeated praziquantel treatment. Integration of fCal thresholds into clinical guidelines may improve management of schistosomiasis-related morbidity.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Wilburn L, Bui HL, Akampurira P, et al. Schistosoma mansoni Infections Are Associated With Fecal Calprotectin Markers of Gut Inflammation After Accounting for HIV, Hepatitis B, and Malaria. J Infect Dis. 2026. PMID: 42053313. doi:10.1093/infdis/jiag094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。